New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Many people who have psoriasis will experience the telltale sign of itchiness or burning. But for people with differing skin tones, that’s where the similarities may end. The symptoms of ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

PSORIASIS is a chronic inflammatory skin disease influenced by both genetic and environmental factors, affecting ...

Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high ...

Psoriasis is an immune-mediated dermatological disorder that occurs when immune system dysfunction leads to excessive skin cell growth and inflammation. Several types of psoriasis exist ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

When doctors chat with patients eye to eye, it’s not just about creating rapport. Certain facial traits may reveal vital ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat ... options if chlorine doesn’t aggravate your skin. Walking during the morning or evening hours ...

Psoriasis is a chronic, relapsing, inflammatory skin and joint disease. Psoriasis affects 1%-3% of the US population. [1] Its effect on physical appearance greatly affects patients' quality of life.